Safety and Immunogenicity of Recombinant COVID-19 Trivalent Protein Vaccine （CHO Cell）LYB002V14 in Booster Vaccination
Clinical trial NCT06167915 · UNKNOWN
Trial details
- NCT number
- NCT06167915
- Sponsor
- Guangzhou Patronus Biotech Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-26
- Primary completion
- 2024-12-26
- Enrollment
- 120
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.